Oral administration of ketotifen in a patient with eosinophilic colitis and severe osteoporosis [15]

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 1072-1074

  Katsinelos, Panos ^a,b   Pilpilidis, Ioannis ^a   Xiarchos, Panos ^a   Christodoulou, Kiriakos ^a   Papagiannis, Adreas ^a   Tsolkas, Panos ^a   Capelidis, Paris ^a   Vasiliadis, Ioannis ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CORTICOSTEROID; KETOTIFEN;

AGED; CASE REPORT; CLINICAL FEATURE; COLITIS; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; EOSINOPHIL COLITIS; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; OSTEOPOROSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036123915     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.05643.x     Document Type: Letter

References (10)

1. Eosinophilic gastroenteritis: 10 years experience
2. Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement
3. Eosinophilic colitis
4. Benefit of Ketotifen in patient with eosinphilic gastroenteritis
5. Resolution of eosinophilic peritonitis with Ketotifen
6. The eosinophil in gut inflammation: Effector or director?
7. The eosinophil leukocyte: Structure and function
8. Eosinophils as effector cells in immunity and hypersensitivity disorders
9. Mast cells from human intestinal lamina propria. Isolation, histochemical subtypes, and functional characterization
10. Eosinophilic gastroenteritis